Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
INDUSTRY
×
pertuzumab
×
Clear all
Filters
3
NCT06884254
2025-10-14
EGC102
EirGenix, Inc.
Phase 3
Withdrawn
NCT03811418
2019-11-26
ATTILA
iOMEDICO AG
Phase 3
Withdrawn